Pure Global
NCT06388109

Positive Peers Intervention Clinical Trial

Randomized Control Trial of Positive Peers mHealth App as a Clinic-based Intervention to Optimize HIV Outcomes Among Young, Minority Persons Living With HIV
MetroHealth Medical Center·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
HIV Infections
Drug/Device/Intervention
Positive Peers mobile app
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
MetroHealth Medical Center
Location
Van Nuys,Newark,Cincinnati,Columbus,Houston,Seattle, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Nov 01, 2027
Enrollment
250 participants
Primary outcome

Viral suppression

Summary

The goal of this clinical trial is to learn if the Positive Peers mobile app intervention
 increases rates of viral suppression in young (13-34 y/o) persons with HIV.
 
 Does use of the Positive Peers app improve viral suppression among young minority persons
 with HIV? What user characteristics are associated with a) viral suppression, b) retention in
 care, and c) perceived HIV-related stigma?
 
 Participants will:
 
 - download the mobile app onto their personal smartphone
 
 - Use the mobile app as they find useful
 
 - complete online surveys at enrollment, 3 mo, 6, mo, 9 mo and 12 months.

ICD-10 classifications
HIV disease resulting in other viral infectionsHIV disease resulting in other bacterial infectionsHIV disease resulting in multiple infectionsAcute HIV infection syndromeHIV disease resulting in other infectious and parasitic diseases
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06388109
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06388109 through Pure Global AI's free database. This phase not specified trial is sponsored by MetroHealth Medical Center and is currently Not yet recruiting. The study focuses on HIV Infections. Target enrollment is 250 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.